Sara L Doorley, MD
Internal Medicine · Albuquerque
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 21 years
- Wright State University Boonshoft School of Medicine, 2005
Offices
1 location · Unm Medical Group Inc · 1,052 clinicians in this group
Looking this up.
Hospitals listed: Unm Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Doorley’s office at (505) 272-2111 to ask if they take your plan before you enroll.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 85.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Unm HospitalAlbuquerque, NMAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of UNM Health System, which runs 2 hospitalsHome of University of New Mexico Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 2 of 5 · 66% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.51 (1.21 to 1.82), Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 6.01 (4.08 to 7.94) · 1,475 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 2.05 (1.47 to 2.63) · 4,908 cases, Jul 2022 – Jun 2024
See every measure and the patient survey for Unm Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 3 better, 3 the same, 1 worse of 7 measures. Readmissions: 1 better, 8 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.51 (1.21 to 1.82) | Worse | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 6.01 (4.08 to 7.94) · 1,475 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 2.05 (1.47 to 2.63) · 4,908 cases | Worse | Jul 2022 – Jun 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.04 to 1.88) · 1,174 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 197.29 (159.48 to 235.1) · 183 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.4 · 186 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.9 · 634 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,456 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.42) · 4,976 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.09 to 0.48) · 5,104 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.25 (0.64 to 3.86) · 546 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.37 to 4.13) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.43 (0.31 to 14.54) · 497 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.65 (2.27 to 9.04) · 531 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.08 (0.67 to 3.49) · 433 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.678 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.88 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.882 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.938 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.457 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.578 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 155 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.5 · 416 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.9 · 80 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 204 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 221 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 506 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.9 to 7.3) · 410 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9 (6.9 to 11.6) · 410 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11.7 · 35 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.4 (8.6 to 14.9) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 717 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,884 patients answered, 12% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 61% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$10,983
Medicare paid this office $10,983 for 88 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 50 | $5,012 | $60 |
| Short return visit (20+ min) | 37 | $1,909 | $42 |
| Long return visit (40+ min) | 11 | $1,418 | $95 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 39 | $638 | $12 |
Who their Medicare patients are
88 Original Medicare patients in 2024. Average age 70 · Women 63% · Also on Medicaid 63% · Health risk score 1.34. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 67% · Diabetes 30% · Chronic kidney disease 23% · Depression 23% · Coronary heart disease 20% · COPD 16% · Heart failure 15% · Atrial fibrillation 13%.
The office billed $44,325, Medicare allowed $17,115 and paid $10,983; for 222 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 88 | 222 | 70 | 1.34 | $44,325 | $10,983 |
| 2023 | 87 | 150 | 70 | 1.64 | $34,527 | $8,558 |
| 2022 | 125 | 193 | 68 | 1.64 | $44,360 | $10,511 |
| 2021 | 121 | 173 | 68 | 1.30 | $40,262 | $11,883 |
| 2017 | 11 | 20 | 71 | 3.36 | $13,525 | $763 |
| 2016 | 30 | 92 | 70 | 3.53 | $29,294 | $6,372 |
| 2015 | 59 | 131 | 62 | 2.81 | $41,054 | $9,361 |
| 2013 | 46 | 206 | 67 | 2.78 | $43,176 | $12,779 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 59 | $5,679 | $56 |
| Short return visit (20+ min) | 29 | $1,606 | $47 |
2022: 2 services
| Return visit (30+ min) | 68 | $5,639 | $57 |
| Short return visit (20+ min) | 50 | $2,653 | $45 |
2021: 2 services
| Return visit (30+ min) | 78 | $7,018 | $75 |
| Short return visit (20+ min) | 27 | $1,492 | $48 |
2016: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $2,443 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,579 | $113 |
| Hospital discharge day management, 30 minutes or less | 13 | $846 | $65 |
2015: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $3,030 | $62 |
| Hospital discharge day management, 30 minutes or less | 24 | $1,552 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,550 | $111 |
| Return visit (30+ min) | 11 | $1,059 | $81 |
2013: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $8,190 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,627 | $108 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $1,227 | $34 |
Medicaid work
$24,411 in 2024
Medicaid paid $24,411 for 391 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 226 | $17,237 |
| Short return visit (20+ min) | 58 | $2,952 |
| HOME/RES VISIT NEW PATIENT LOW MDM 30 MINUTES | 19 | $1,723 |
| HOME/RES VST NEW MOD MDM 60 | 14 | $1,604 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 74 | $895 |
| 2024 | 391 | 5 | 28 | $24,411 |
| 2023 | 360 | 2 | 32 | $19,710 |
| 2022 | 514 | 3 | 39 | $22,370 |
| 2021 | 271 | 2 | 31 | $11,799 |
| 2020 | 79 | 2 | 37 | $6,606 |
| 2019 | 124 | 3 | 43 | $14,107 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 318 | $18,055 |
| Short return visit (20+ min) | 42 | $1,655 |
2022
| Return visit (30+ min) | 411 | $18,660 |
| Hospital outpatient clinic visit for assessment and management of a patient | 26 | $1,890 |
| Short return visit (20+ min) | 77 | $1,820 |
2021
| Return visit (30+ min) | 237 | $9,863 |
| Hospital outpatient clinic visit for assessment and management of a patient | 34 | $1,935 |
2020
| PSYCHOTHERAPY W/PATIENT 30 MINUTES | 38 | $6,606 |
| Clinic visit/encounter, all-inclusive | 41 | $0 |
2019
| PSYCHOTHERAPY W/PATIENT 30 MINUTES | 63 | $10,030 |
| Short return visit (20+ min) | 39 | $4,077 |
| Clinic visit/encounter, all-inclusive | 22 | $0 |
Drugs they prescribed that Part D paid
$256,534
Pharmacies billed $256,534 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 9% of their Part D prescriptions (226 of 2,598) in 2024. A higher opioid share than 9 in 10 peers; the typical internal medicine clinician is at 1%. Long-acting opioids: 29% of their opioid prescriptions.
2,215 generic and 369 brand-name prescriptions · $256,534 in drug cost · 71 antibiotic prescriptions to 37 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 32 | $40,948 | $1,280 |
| Ozempic | 21 | $27,426 | $1,306 |
| Trulicity | 22 | $24,823 | $1,128 |
| Lantus Solostar | 27 | $5,045 | $187 |
| Buprenorphine-Naloxone | 34 | $4,909 | $144 |
See all 66 drugs
| Eliquis | 32 | $40,948 | $1,280 |
| Ozempic | 21 | $27,426 | $1,306 |
| Trulicity | 22 | $24,823 | $1,128 |
| Lantus Solostar | 27 | $5,045 | $187 |
| Buprenorphine-Naloxone | 34 | $4,909 | $144 |
| Gabapentin | 153 | $3,144 | $21 |
| Oxycodone | 92 | $2,294 | $25 |
| Fluticasone-Salmeterol | 16 | $2,219 | $139 |
| Pregabalin | 25 | $1,830 | $73 |
| Albuterol Sulfate Hfa | 49 | $1,679 | $34 |
| Emtricitabine-Tenofovir Disop | 12 | $1,502 | $125 |
| Baclofen | 63 | $1,439 | $23 |
| Atorvastatin | 129 | $1,352 | $10 |
| Duloxetine | 25 | $1,293 | $52 |
| Hydrocodone-Acetaminophen | 38 | $1,120 | $29 |
| Desmopressin Acetate | 11 | $1,099 | $100 |
| Levothyroxine | 94 | $1,091 | $12 |
| Morphine Sulfate Er | 39 | $865 | $22 |
| Bupropion Xl | 30 | $827 | $28 |
| Mirtazapine | 33 | $739 | $22 |
| Venlafaxine Hcl Er | 20 | $731 | $37 |
| Lisinopril | 103 | $722 | $7 |
| Oxycodone-Acetaminophen | 11 | $614 | $56 |
| Diclofenac | 20 | $551 | $28 |
| Metoprolol | 33 | $527 | $16 |
| Prazosin | 15 | $526 | $35 |
| Losartan | 39 | $510 | $13 |
| Amlodipine Besylate | 69 | $491 | $7 |
| Omeprazole | 42 | $419 | $10 |
| Metformin | 42 | $400 | $10 |
| Ibuprofen | 25 | $380 | $15 |
| Tizanidine | 21 | $372 | $18 |
| Fluticasone Propionate | 34 | $328 | $10 |
| Famotidine | 23 | $324 | $14 |
| Topiramate | 29 | $315 | $11 |
| Glipizide Er | 13 | $267 | $21 |
| Carvedilol | 30 | $266 | $9 |
| Methadone | 22 | $252 | $11 |
| Simvastatin | 31 | $244 | $8 |
| Metformin Hcl Er | 26 | $243 | $9 |
| Alendronate | 17 | $235 | $14 |
| Sertraline | 20 | $208 | $10 |
| Lovastatin | 18 | $191 | $11 |
| Potassium Chloride | 11 | $185 | $17 |
| Amoxicillin-Clavulanate Potass | 21 | $151 | $7 |
| Memantine | 11 | $148 | $13 |
| Oxybutynin Chloride Er | 13 | $136 | $10 |
| Furosemide | 24 | $136 | $6 |
| Trazodone | 19 | $135 | $7 |
| Nitroglycerin | 12 | $125 | $10 |
| Ondansetron | 12 | $122 | $10 |
| Spironolactone | 12 | $110 | $9 |
| Methocarbamol | 19 | $92 | $5 |
| Meclizine | 13 | $89 | $7 |
| Acyclovir | 18 | $89 | $5 |
| Pantoprazole | 14 | $86 | $6 |
| Metoprolol | 19 | $85 | $4 |
| Sumatriptan | 15 | $75 | $5 |
| Tramadol | 20 | $74 | $4 |
| Hydrochlorothiazide | 18 | $67 | $4 |
| Cyclobenzaprine | 11 | $62 | $6 |
| Clonazepam | 19 | $61 | $3 |
| Azithromycin | 11 | $60 | $5 |
| Escitalopram | 14 | $50 | $4 |
| Zolpidem | 24 | $32 | $1 |
| Prednisone | 13 | $15 | $1 |
Year by year
| 2024 | 2,598 | 191 | 9% (226) | 14% | $256,534 |
| 2023 | 2,450 | 201 | 9% (219) | None | $283,129 |
| 2022 | 2,108 | 213 | 7% (147) | 13% | $228,275 |
| 2021 | 629 | 141 | 10% (60) | 12% | $44,165 |
| 2020 | 548 | 88 | 6% (34) | None | $24,331 |
| 2019 | 952 | 126 | 4% (37) | None | $71,915 |
| 2018 | 465 | 93 | None | None | $39,662 |
| 2017 | 226 | 57 | 7% (16) | None | $19,267 |
| 2016 | 584 | 92 | 8% (49) | None | $36,218 |
| 2015 | 597 | 81 | 7% (40) | None | $25,815 |
| 2014 | 329 | 48 | 8% (27) | None | $11,645 |
| 2013 | 496 | 70 | 9% (45) | 28% | $26,188 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 62 drugs
| Eliquis | 42 | $37,962 | $904 |
| Trulicity | 17 | $20,503 | $1,206 |
| Buprenorphine-Naloxone | 29 | $5,350 | $184 |
| Pregabalin | 38 | $4,217 | $111 |
| Gabapentin | 161 | $2,789 | $17 |
| Oxycodone | 106 | $2,385 | $22 |
| Atorvastatin | 117 | $2,250 | $19 |
| Emtricitabine-Tenofovir Disop | 15 | $1,911 | $127 |
| Levothyroxine | 110 | $1,560 | $14 |
| Baclofen | 45 | $1,515 | $34 |
| Hydrocodone-Acetaminophen | 43 | $1,258 | $29 |
| Albuterol Sulfate Hfa | 35 | $1,236 | $35 |
| Duloxetine | 25 | $926 | $37 |
| Amlodipine Besylate | 71 | $898 | $13 |
| Lisinopril | 99 | $880 | $9 |
| Tizanidine | 31 | $756 | $24 |
| Diclofenac | 35 | $741 | $21 |
| Mirtazapine | 15 | $666 | $44 |
| Tamsulosin | 22 | $655 | $30 |
| Losartan | 43 | $611 | $14 |
| Pantoprazole | 31 | $532 | $17 |
| Methadone | 19 | $479 | $25 |
| Omeprazole | 37 | $478 | $13 |
| Famotidine | 28 | $458 | $16 |
| Metoprolol | 21 | $456 | $22 |
| Fluticasone Propionate | 37 | $419 | $11 |
| Metformin | 46 | $414 | $9 |
| Hydroxyzine | 13 | $368 | $28 |
| Metformin Hcl Er | 14 | $358 | $26 |
| Morphine Sulfate Er | 22 | $345 | $16 |
| Ibuprofen | 33 | $340 | $10 |
| Alendronate | 16 | $332 | $21 |
| Lamotrigine | 19 | $329 | $17 |
| Simvastatin | 25 | $309 | $12 |
| Lovastatin | 14 | $264 | $19 |
| Venlafaxine | 12 | $248 | $21 |
| Pravastatin | 11 | $246 | $22 |
| Potassium Chloride | 15 | $237 | $16 |
| Carvedilol | 30 | $235 | $8 |
| Finasteride | 11 | $221 | $20 |
| Sertraline | 25 | $221 | $9 |
| Topiramate | 17 | $208 | $12 |
| Glipizide Er | 14 | $200 | $14 |
| Levetiracetam | 14 | $188 | $13 |
| Trazodone | 19 | $184 | $10 |
| Aripiprazole | 12 | $164 | $14 |
| Buspirone | 11 | $142 | $13 |
| Diazepam | 11 | $141 | $13 |
| Amoxicillin-Clavulanate Potass | 11 | $139 | $13 |
| Furosemide | 27 | $135 | $5 |
| Oxybutynin Chloride Er | 14 | $131 | $9 |
| Risperidone | 12 | $124 | $10 |
| Methocarbamol | 18 | $118 | $7 |
| Lactulose | 19 | $112 | $6 |
| Cyclobenzaprine | 16 | $111 | $7 |
| Meclizine | 12 | $81 | $7 |
| Clonazepam | 20 | $74 | $4 |
| Hydrochlorothiazide | 15 | $64 | $4 |
| Zolpidem | 22 | $45 | $2 |
| Tramadol | 16 | $41 | $3 |
| Prednisone | 12 | $39 | $3 |
| Metoprolol | 13 | $31 | $2 |
2022: 51 drugs
| Trulicity | 18 | $29,273 | $1,626 |
| Eliquis | 31 | $24,303 | $784 |
| Emtricitabine-Tenofovir Disop | 15 | $12,901 | $860 |
| Buprenorphine-Naloxone | 37 | $10,782 | $291 |
| Gabapentin | 138 | $3,709 | $27 |
| Shingrix | 15 | $2,714 | $181 |
| Pregabalin | 40 | $2,162 | $54 |
| Venlafaxine Hcl Er | 18 | $2,069 | $115 |
| Insulin Lispro Kwikpen U-100 | 12 | $2,043 | $170 |
| Albuterol Sulfate Hfa | 46 | $1,927 | $42 |
| Atorvastatin | 135 | $1,760 | $13 |
| Diclofenac | 66 | $1,346 | $20 |
| Baclofen | 47 | $1,235 | $26 |
| Levothyroxine | 63 | $1,177 | $19 |
| Tizanidine | 23 | $894 | $39 |
| Oxycodone | 61 | $869 | $14 |
| Fluticasone Propionate | 36 | $783 | $22 |
| Hydrocodone-Acetaminophen | 36 | $726 | $20 |
| Metoprolol | 21 | $687 | $33 |
| Aripiprazole | 11 | $659 | $60 |
| Lisinopril | 96 | $655 | $7 |
| Duloxetine | 16 | $615 | $38 |
| Losartan | 31 | $589 | $19 |
| Omeprazole | 39 | $511 | $13 |
| Tamsulosin | 23 | $427 | $19 |
| Bupropion Xl | 18 | $391 | $22 |
| Amlodipine Besylate | 50 | $363 | $7 |
| Morphine Sulfate Er | 16 | $347 | $22 |
| Cyclobenzaprine | 20 | $300 | $15 |
| Lamotrigine | 11 | $263 | $24 |
| Hydroxyzine | 16 | $263 | $16 |
| Ibuprofen | 17 | $254 | $15 |
| Trazodone | 29 | $247 | $9 |
| Metformin | 46 | $239 | $5 |
| Famotidine | 14 | $221 | $16 |
| Methadone | 12 | $214 | $18 |
| Pantoprazole | 17 | $202 | $12 |
| Carvedilol | 20 | $196 | $10 |
| Venlafaxine | 11 | $183 | $17 |
| Dicyclomine | 12 | $165 | $14 |
| Simvastatin | 23 | $150 | $7 |
| Sertraline | 25 | $121 | $5 |
| Potassium Chloride | 19 | $118 | $6 |
| Alendronate | 11 | $114 | $10 |
| Metformin Hcl Er | 17 | $107 | $6 |
| Clonazepam | 19 | $90 | $5 |
| Furosemide | 18 | $87 | $5 |
| Methocarbamol | 19 | $85 | $4 |
| Metoprolol | 22 | $51 | $2 |
| Lactulose | 14 | $39 | $3 |
| Tramadol | 14 | $22 | $2 |
2021: 16 drugs
| Buprenorphine-Naloxone | 14 | $5,673 | $405 |
| Gabapentin | 23 | $747 | $32 |
| Baclofen | 17 | $702 | $41 |
| Atorvastatin | 44 | $688 | $16 |
| Levothyroxine | 24 | $553 | $23 |
| Tizanidine | 11 | $495 | $45 |
| Albuterol Sulfate Hfa | 15 | $490 | $33 |
| Oxycodone | 18 | $369 | $20 |
| Losartan | 15 | $299 | $20 |
| Diclofenac | 13 | $295 | $23 |
| Omeprazole | 13 | $272 | $21 |
| Hydrocodone-Acetaminophen | 13 | $148 | $11 |
| Lisinopril | 27 | $134 | $5 |
| Carvedilol | 12 | $99 | $8 |
| Metformin | 15 | $76 | $5 |
| Amlodipine Besylate | 11 | $59 | $5 |
2020: 16 drugs
| Buprenorphine-Naloxone | 19 | $5,761 | $303 |
| Progesterone | 24 | $699 | $29 |
| Ventolin Hfa | 11 | $693 | $63 |
| Oxycodone | 24 | $571 | $24 |
| Spironolactone | 18 | $482 | $27 |
| Gabapentin | 15 | $467 | $31 |
| Levothyroxine | 24 | $343 | $14 |
| Trazodone | 21 | $336 | $16 |
| Atorvastatin | 11 | $180 | $16 |
| Omeprazole | 20 | $179 | $9 |
| Lisinopril | 28 | $157 | $6 |
| Ibuprofen | 11 | $135 | $12 |
| Simvastatin | 17 | $107 | $6 |
| Fluoxetine | 14 | $105 | $8 |
| Sertraline | 14 | $86 | $6 |
| Metformin | 19 | $62 | $3 |
2019: 30 drugs
| Suboxone | 32 | $12,235 | $382 |
| Buprenorphine-Naloxone | 46 | $11,120 | $242 |
| Aripiprazole | 12 | $2,328 | $194 |
| Proair Hfa | 16 | $1,243 | $78 |
| Gabapentin | 40 | $1,201 | $30 |
| Ventolin Hfa | 17 | $964 | $57 |
| Estradiol | 16 | $868 | $54 |
| Duloxetine | 19 | $536 | $28 |
| Levothyroxine | 35 | $424 | $12 |
| Lisinopril | 64 | $407 | $6 |
| Tamsulosin | 26 | $387 | $15 |
| Trazodone | 21 | $379 | $18 |
| Spironolactone | 16 | $317 | $20 |
| Metoprolol | 13 | $314 | $24 |
| Terazosin | 23 | $292 | $13 |
| Oxycodone | 14 | $269 | $19 |
| Atorvastatin | 23 | $259 | $11 |
| Propranolol | 12 | $258 | $22 |
| Divalproex Sodium Er | 16 | $228 | $14 |
| Quetiapine | 11 | $201 | $18 |
| Omeprazole | 24 | $189 | $8 |
| Levetiracetam | 16 | $176 | $11 |
| Metformin | 22 | $175 | $8 |
| Sertraline | 16 | $105 | $7 |
| Simvastatin | 16 | $90 | $6 |
| Tramadol | 13 | $81 | $6 |
| Montelukast | 13 | $70 | $5 |
| Carvedilol | 13 | $65 | $5 |
| Risperidone | 13 | $50 | $4 |
| Hydrochlorothiazide | 12 | $27 | $2 |
2018: 6 drugs
| Suboxone | 77 | $22,414 | $291 |
| Gabapentin | 18 | $288 | $16 |
| Lisinopril | 39 | $210 | $5 |
| Levothyroxine | 12 | $121 | $10 |
| Metformin | 12 | $56 | $5 |
| Amlodipine Besylate | 11 | $42 | $4 |
2016: 17 drugs
| Suboxone | 25 | $4,302 | $172 |
| Buprenorphine | 16 | $1,206 | $75 |
| Tamsulosin | 20 | $630 | $31 |
| Hydrocodone-Acetaminophen | 12 | $361 | $30 |
| Bupropion Xl | 11 | $286 | $26 |
| Gabapentin | 17 | $244 | $14 |
| Atorvastatin | 13 | $235 | $18 |
| Fosinopril | 17 | $176 | $10 |
| Omeprazole | 22 | $126 | $6 |
| Bupropion Hcl Sr | 13 | $122 | $9 |
| Methadone | 13 | $112 | $9 |
| Metformin | 18 | $88 | $5 |
| Risperidone | 14 | $79 | $6 |
| Clonazepam | 27 | $75 | $3 |
| Trazodone | 11 | $67 | $6 |
| Benazepril | 11 | $51 | $5 |
| Hydrochlorothiazide | 12 | $25 | $2 |
2015: 15 drugs
| Suboxone | 18 | $4,190 | $233 |
| Proair Hfa | 11 | $688 | $63 |
| Tamsulosin | 19 | $526 | $28 |
| Atorvastatin | 22 | $467 | $21 |
| Gabapentin | 18 | $435 | $24 |
| Fosinopril | 43 | $385 | $9 |
| Omeprazole | 35 | $265 | $8 |
| Amlodipine Besylate | 27 | $165 | $6 |
| Hydrocodone-Acetaminophen | 14 | $132 | $9 |
| Metformin | 13 | $96 | $7 |
| Carvedilol | 13 | $79 | $6 |
| Hydrochlorothiazide | 20 | $60 | $3 |
| Atenolol | 12 | $55 | $5 |
| Clonazepam | 12 | $50 | $4 |
| Furosemide | 13 | $46 | $4 |
2014: 5 drugs
| Tamsulosin | 18 | $727 | $40 |
| Amlodipine Besylate | 31 | $192 | $6 |
| Fosinopril | 20 | $182 | $9 |
| Metformin | 12 | $94 | $8 |
| Simvastatin | 11 | $53 | $5 |
2013: 12 drugs
| Buprenorphine-Naloxone | 15 | $2,852 | $190 |
| Suboxone | 17 | $2,048 | $120 |
| Atorvastatin | 12 | $334 | $28 |
| Metoprolol | 12 | $273 | $23 |
| Risperidone | 11 | $272 | $25 |
| Methadone | 21 | $258 | $12 |
| Tamsulosin | 15 | $188 | $13 |
| Amlodipine Besylate | 26 | $167 | $6 |
| Oxycodone-Acetaminophen | 15 | $153 | $10 |
| Metformin | 21 | $117 | $6 |
| Simvastatin | 14 | $93 | $7 |
| Clonazepam | 17 | $91 | $5 |
Money from drug and device companies
$93 in 2025
| 2025 | 2 | 5 | None | $93 |
| 2019 | 1 | 1 | None | $19 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Mavyret | $68 | 4 payments
|
| Exact Sciences | The Cologuard Plus Collection Kit | $24 | 1 payment
|
See all 5 published payments
| Abbvie | Meals · 2025-08-06 | Mavyret | $15 |
| Abbvie | Meals · 2025-06-10 | Mavyret | $19 |
| Exact Sciences | Meals · 2025-05-15 | The Cologuard Plus Collection Kit | $24 |
| Abbvie | Meals · 2025-03-26 | Mavyret | $18 |
| Abbvie | Meals · 2025-02-18 | Mavyret | $16 |
See earlier years (2019)
2019: $19
| Alkermes | Vivitrol | $19 | 1 payment
|
Professional record
- NPI
- 1336378314
- Licence
- NM MD2017-0921, NY 251659
- Trained
- Wright State University Boonshoft School of Medicine, 2005 · 21 years ago
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 800 Bradbury Dr Se Ste 116, Albuquerque, NM, 87106
- NPI first listed
- 2009-07-10
- NPI last updated
- 2025-02-13
- NPI record certified
- 2025-02-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 751 S Bascom Ave, San Jose, CA, 95128
This office lists an electronic records connection.